[1. UNAIDS/WHO. Antiretroviral therapy and sexual transmission of HIV. Geneva. 1 February 2008. www.who.int/entity/hiv/mediacentre/080201_hivtransmission_en.pdf.]Search in Google Scholar
[2. Andia I, Kaida A, Maier M, Guzman D, Emenyonu N, Pepper L, et al. Highly active antiretroviral therapy and increased use of contraceptives among HIVpositive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Am J Public Health. 2009; 99:340-7.10.2105/AJPH.2007.129528]Search in Google Scholar
[3. Valverde EE, Cassetti I, Metsch LR, Bugarin G, Bofill L, Laurido M, et al. Sex risk practices among HIVpositive individuals in Buenos Aires, Argentina. AIDS Pat Care STD. 2009; 23:551-6.10.1089/apc.2008.0094]Search in Google Scholar
[4. World Health Organization (WHO). Reproductive choices and family planning for people living with HIV. Geneva:WHO, 2006.]Search in Google Scholar
[5. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLosMedicine. February 9, 2010.10.1371/journal.pmed.1000229]Search in Google Scholar
[6. Warakamin S, Boonthai N, Tangcharoensathien V. Induced abortion in Thailand: current situation in public hospitals and legal perspectives. Reprod Health Matters. 2004; 12 (Suppl):147-56.10.1016/S0968-8080(04)24018-6]Open DOISearch in Google Scholar
[7. Ananworanich J, Bernard H. Intermittent therapy for the treatment of chronic HIV infection. AIDS. 2007; 21:123-34.10.1097/01.aids.0000256414.91105.8e17197802]Open DOISearch in Google Scholar
[8. Aidsmap news. http://www.aidsmap.com/en/news/4E9D555B-18FB-4D56-B912-2C28AFCCD36B.asp.]Search in Google Scholar
[9. Vernazza P, Hirschel B, Flepp M. Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitment antirtroviral efficace ne transmettent pas le VIH par voie sexuelle (in French). Bulletin Medecins Suisses. 2008; 89:165-69.10.4414/bms.2008.13252]Search in Google Scholar
[10. Shine AK. Catching up on contraception. Aust Fam Physician. 2009; 38:380-2.]Search in Google Scholar
[11. Feldblum PJ, Nasution MD, Hoke TH, Van Damme K, Turner AN, Gmach R, et al. Pregnancy among sex workers participating in a condom intervention trial highlights the need for dual protection. Contraception. 2007; 76:105-10.10.1016/j.contraception.2007.04.00917656179]Search in Google Scholar
[12. British HIV Association. UK Guidelines for the management of sexual and reproductive health of people living with HIV infection. 2008. Available at: www.bhiva.org.]Search in Google Scholar
[13. Thailand DHS, 1987, 1997. Thailand Reproductive Health Profile 2003 (unpublished). Available at: www.searo.who.int/LinkFiles/Family_Planning_Fact_Sheets_thailand.pdf]Search in Google Scholar
[14. Heikinheimo O, Lähteenmäki P. Contraception and HIV infection in women. Hum Reprod Update. 2009; 15:165-76.10.1093/humupd/dmn049263908518978360]Search in Google Scholar
[15. Laher F, Todd CS, Stibich MA, Phofa R, Behane X, Mohapi L, et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav. 2009;13(Suppl 1):47-54.10.1007/s10461-009-9544-z19308719]Search in Google Scholar
[16. Asboe D, Catalan J, Mandalia S, Dedes N, Florence E, Schrooten W, et al. Sexual dysfunction in HIVpositive men is multi-factorial: A study of prevalence and associated factors. AIDS Care. 2007; 19:955 -65.10.1080/0954012070120984717851990]Open DOISearch in Google Scholar
[17. Moreno-Perez O, Escoin C, Serna-Candel C, Arias N, Alfayate R, Boix V, et al. Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART. Presented at International Conference in Endocrinology, Istanbul, April, 2009.]Search in Google Scholar
[18. Lara DK, Grossman DA, Muñoz JE, Rosario SR, Gómez BJ, García SG. Acceptability and use of the female condom and diaphragm among sex workers in Dominican Republic: results from a prospective study. AIDS Educ Prev. 2009; 21:538-51.10.1521/aeap.2009.21.6.538]Open DOISearch in Google Scholar
[19. Mekonnen T, Robays J, Negassa H, Fiesha G, Yadeta M, Bekele Y, et al. Acceptability of female condom among women involved in prostitution in Addis Ababa, Ethiopia. Presented at Intern Conf AIDS. July, 2002. (Abstract no. MoPeF3865]Search in Google Scholar
[20. Global Campaign for Microbicides. Methods for Improving Reproductive Health in Africa (MIRA). http://www.global-campaign.org/MIRA.htm]Search in Google Scholar
[21. Ngubane N, Patel D, Newell ML, Coovadia HM, Rollins N, Coutsoudis A, et al. Messages about dual contraception in areas of high HIV prevalence are not heeded. S Afr Med J.2008; 98:209-12.]Search in Google Scholar
[22. Mallet J, Kalambi V. Coerced and forced sterilization of HIV-positive women in Namibia. HIV AIDS Policy Law Rev. 2008; 13:77-8.]Search in Google Scholar
[23. Practice Committee of the American Society for Reproductive Medicine. Hormonal contraception: recent advances and controversies. 2008 ]Search in Google Scholar
[24. Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, Chintu N, Stringer JS. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS. 2009: 23;1377-82.10.1097/QAD.0b013e32832cbca8]Open DOISearch in Google Scholar
[25. Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS. MTCT-Plus InitiativeHormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-plus initiative. AIDS. 2009; 23 (Suppl 1):S69-77.10.1097/01.aids.0000363779.65827.e0]Search in Google Scholar
[26. Frölich M, Burhenne J, Martin-Facklam M, Weiss J, von Wolff M, Strowitzki T, et al. Oral contraception does not alter single dose saquinavir pharmacokinetics in women. Br J Clin Pharmacol. 2004; 57: 244-52.10.1111/j.1365-2125.2003.01983.x]Open DOISearch in Google Scholar
[27. Schöller-Gyüre M, Kakuda TN, Woodfall B, Aharchi F, Peeters M, Vandermeulen K, et al. Effect of steadystate etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone. Contraception. 2009; 80:44-52.10.1016/j.contraception.2009.01.009]Open DOISearch in Google Scholar
[28. Nanda K, Amaral E, Hays M, Viscola MA, Mehta N, Bahamondes L. Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy. Fertil Steril. 2008; 90:965-71.10.1016/j.fertnstert.2007.07.1348]Open DOISearch in Google Scholar
[29. Watts DH, Park JG, Cohn SE, Yu S, Hitti J, Stek A, et al. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy ACTG A5093. Contraception. 2008; 77:84-90.10.1016/j.contraception.2007.10.002]Search in Google Scholar
[30. Panel on Antiretroviral guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.]Search in Google Scholar
[31. Womack J, Richman S, Tien PC, Grey M, Williams A. Hormonal contraception and HIV-positive women: metabolic concerns and management strategies. J Midwifery Womens Health. 2008; 53:362-75.10.1016/j.jmwh.2008.01.006]Search in Google Scholar
[32. Charonis G, Larsson PG. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess. Acta Obstet Gynecol Scand. 2009; 88:680-4.10.1080/00016340902893678]Open DOISearch in Google Scholar
[33. Hodoglugil NN, Aslan D, Bertan M. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception. 2000; 61:359-64.10.1016/S0010-7824(00)00118-9]Open DOISearch in Google Scholar
[34. Joesoef MR, Karundeng A, Runtupalit C, Moran JS, Lewis JS, Ryan CA. High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception. 2001; 64:169-72.10.1016/S0010-7824(01)00246-3]Open DOISearch in Google Scholar
[35. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007; 197: 144.e1-8.10.1016/j.ajog.2007.03.031273075417689627]Search in Google Scholar
[36. WHO policy on microbicides. www.who.int]Search in Google Scholar
[37. D’Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection.- Curr Pharm Des. 2004; 10:315-36.10.2174/138161204338637414754390]Search in Google Scholar
[38. Batár I. State-of-the-art of non-hormonal methods of contraception: II. Chemical barrier contraceptives. Eur J Contracept Reprod Health Care. 2010; 15:89-95.10.3109/1362518090346232620055729]Search in Google Scholar
[39. Karim SA, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, et al. Safety and effectiveness of vaginal microbicides bufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 trial [Abstract 48LB]. Presented at 16th Conference on Retroviruses and Opportunistic Infections. February 8-11, 2009, Montreal.]Search in Google Scholar
[40. Microbicides Development Programme. http://www.mdp.mrc.ac.uk/]Search in Google Scholar
[41. Microbicides Trials Network, MTN-002, www.mtnstopshiv.org.]Search in Google Scholar